MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism
about
Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteinsGenome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisonsCardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart.Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placentaPreferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cellsTumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIVSweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.Genetic variation in microRNA networks: the implications for cancer research.Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis.MicroRNAs as promising biomarkers in cancer diagnostics.Regulation of TRIB3 mRNA and protein in breast cancer.Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiationIntegrating microRNAs into a system biology approach to acute lung injuryReprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart.The emerging role of microRNAs in drug responsesEnrichment Analysis Identifies Functional MicroRNA-Disease Associations in HumansPlasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer.The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins.Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs.The targeting and functions of miRNA-383 are mediated by FMRP during spermatogenesis.MicroRNA expression and its association with DNA repair in preimplantation embryos.Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasisOverexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9.Evaluation of the mirn23a Cluster through an iTRAQ-based Quantitative Proteomic Approach.TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer.Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy.miRNAs as biomarkers in colorectal cancer diagnosis and prognosis.Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance.Implications of miRNAs in Colorectal Cancer Chemoresistance.Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes.Circulating miRNAs as biomarkers for endocrine disorders.miR clusters target cellular functional complexes by defining their degree of regulatory freedom.Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer.Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells.MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
P2860
Q28579249-AC2B7D36-B6A7-4A10-A69C-3C0AEA2C39C6Q28741878-8E3028F0-F542-4785-822D-7DC6DE7C512FQ30528601-F7209502-4ECF-4F38-A361-9E7C68212882Q31133417-0A506769-D7C0-4788-A18F-9A55867C4DDDQ33648268-4936D198-3E73-47EE-B6ED-E50A6C7C8929Q33700623-403EA1B8-9005-424F-A1A7-54A53AC4DD8EQ33862088-401A8F5C-2543-4DE3-841A-523A947C4704Q33948651-65CB5A7B-022E-4F20-B02A-8342A1209A2FQ34177121-80DE2BA3-DF4B-4156-9747-CEE848410212Q34404162-DF3F6DCE-6F72-4965-A9DB-0D3AF5F0F5ECQ34417467-94333B53-7183-48BB-BB38-A75FBBEF840DQ34490037-0A8BE382-B5CD-42F0-AC1E-EFF700CA4882Q34646522-8CAF18D7-7B09-454C-9187-C3DD9BFCBC37Q34778041-3FDA3954-E95A-4E37-B9B5-550C286C3986Q35164003-A2DEB545-63B6-4022-BB82-ABBE89954B92Q35599477-22A7A043-C796-4ECE-8C4A-7259974333D0Q35752431-FE40F975-B81D-486F-AFB6-1E5D8641C159Q35987115-972EAF6E-C8FB-4742-A89C-D1DAB7DE3787Q36192675-D6CB89C5-F1BB-450E-91F9-17CD258B9559Q36210780-976F6894-3CDF-4049-AA40-38B29CACC047Q36216104-2B004FD0-9835-4CD8-8C6F-441E6BE5C20FQ36299753-05DF0063-319D-497A-96B3-DC30F8FED783Q36310047-A6163617-7817-47CA-806E-26EDBF619705Q36907062-F6599904-9647-4832-872C-44C4BFA54330Q37034049-D92D13F1-0CC6-4499-ADCB-3B9207997097Q37087420-9BFAD9CC-2CF4-4568-9490-90C1F7127EBBQ37407242-8EC4CE75-DD9F-4221-827D-EC915EA9453EQ37639167-2DAAA51F-9C1F-41E7-B194-A4EC25639C9CQ37699330-5AECC39E-B22B-4879-AA38-59F4664948A8Q37728744-E8357338-301D-4718-B845-E3BE70639FD8Q37764707-B39DF7CF-A4FB-4F90-B567-30DA4DEA15F4Q37799873-D048D223-F578-4AFF-8D21-574998452C63Q38200600-3FA6E9A7-5164-4D2E-904A-56850DE6ED62Q38370358-831312F7-AD0A-4236-B8F3-418758C94CBCQ38500323-0E398B1E-551E-4A75-9412-64229A6B0AEBQ38503895-6FDF0FB5-DACA-477E-99D0-82895A52C0DCQ38771877-20628DCF-B850-49B0-B5DA-85AF002BE985Q38977601-3F6E8015-7EA3-431B-9919-F365D208B63FQ39072564-8B2D8943-FFA5-4F48-80CC-A34D45157FFDQ39090370-C5AFAB34-00A1-41AB-AD15-DB88304A5B15
P2860
MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@ast
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@en
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@nl
type
label
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@ast
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@en
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@nl
prefLabel
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@ast
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@en
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@nl
P2093
P2860
P3181
P1433
P1476
MiR-24 tumor suppressor activi ...... ugh a target site polymorphism
@en
P2093
Debabrata Banerjee
Glenn Merlino
Jingfang Ju
Joseph R Bertino
Prasun J Mishra
Pravin J Mishra
Rita Humeniuk
P2860
P3181
P356
10.1371/JOURNAL.PONE.0008445
P407
P577
2009-12-24T00:00:00Z